Tulobuterol: Difference between revisions

	WikiDoc Resources for Tulobuterol
Articles
Most recent articles on Tulobuterol Most cited articles on Tulobuterol Review articles on Tulobuterol Articles on Tulobuterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tulobuterol Images of Tulobuterol Photos of Tulobuterol Podcasts & MP3s on Tulobuterol Videos on Tulobuterol
Evidence Based Medicine
Cochrane Collaboration on Tulobuterol Bandolier on Tulobuterol TRIP on Tulobuterol
Clinical Trials
Ongoing Trials on Tulobuterol at Clinical Trials.gov Trial results on Tulobuterol Clinical Trials on Tulobuterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tulobuterol NICE Guidance on Tulobuterol NHS PRODIGY Guidance FDA on Tulobuterol CDC on Tulobuterol
Books
Books on Tulobuterol
News
Tulobuterol in the news Be alerted to news on Tulobuterol News trends on Tulobuterol
Commentary
Blogs on Tulobuterol
Definitions
Definitions of Tulobuterol
Patient Resources / Community
Patient resources on Tulobuterol Discussion groups on Tulobuterol Patient Handouts on Tulobuterol Directions to Hospitals Treating Tulobuterol Risk calculators and risk factors for Tulobuterol
Healthcare Provider Resources
Symptoms of Tulobuterol Causes & Risk Factors for Tulobuterol Diagnostic studies for Tulobuterol Treatment of Tulobuterol
Continuing Medical Education (CME)
CME Programs on Tulobuterol
International
Tulobuterol en Espanol Tulobuterol en Francais
Business
Tulobuterol in the Marketplace Patents on Tulobuterol
Experimental / Informatics
List of terms related to Tulobuterol

Tulobuterol
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Inhaled, oral
ATC code	R03AC11 (WHO) ;
Identifiers
	IUPAC name (RS)-2-(tert-butylamino)-1-(2-chlorophenyl)ethanol;
CAS Number	41570-61-0 ;
PubChem CID	5606;
ChemSpider	5404 ;
UNII	591I9SU0F7;
KEGG	D02151 ;
ChEMBL	ChEMBL1159717 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C12H18ClNO
Molar mass	227.730 g/mol
3D model (JSmol)	Interactive image;
	SMILES Clc1ccccc1C(O)CNC(C)(C)C;
	InChI InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3 ; Key:YREYLAVBNPACJM-UHFFFAOYSA-N ;
(what is this?) (verify)

← Older edit Newer edit →

VisualWikitext

Revision as of 18:16, 8 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tulobuterol (INN) is a long-acting beta2-adrenergic receptor agonist, marketed in Japan as a transdermal patch under the name Hokunalin tape (ホクナリンテープ).^[1]

Currently, it is only legal in 6 countries: Japan, Germany, China, Bangladesh, Pakistan, and Venezuela.

References

↑ PMID 15212190 (PMID 15212190)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Template:Asthma and copd rx

[1] PMID 15212190 (PMID 15212190)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

[1]

@@ Line 1: / Line 1: @@
 {{Drugbox
-| IUPAC_name        = 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol
+| Verifiedfields = changed
-| image             = Tulobuterol.svg
+| Watchedfields = changed
-| CAS_number        = 41570-61-0
+| verifiedrevid = 470618776
-| CAS_supplemental  =
+| IUPAC_name = (''RS'')-2-(''tert''-butylamino)-1-(2-chlorophenyl)ethanol
-| ATC_prefix        = R03
+| image = Tulobuterol00.png
-| ATC_suffix        = AC11
+| image2 = Tulobuterol000.png
-| ATC_supplemental  =
-| PubChem           = 5606
+<!--Clinical data-->
-| DrugBank          =
+| tradename =
-| C=12 | H=18 | Cl=1 | N=1 | O=1
+| Drugs.com = {{drugs.com|international|tulobuterol}}
-| molecular_weight  = 227.730 g/mol
+| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
-| bioavailability   =
+| pregnancy_US = <!-- A / B            / C / D / X -->
-| protein_bound     =
+| pregnancy_category =
-| metabolism        =
+| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
-| elimination_half-life =
+| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
-| excretion         =
+| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
-| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
+| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
-| pregnancy_US      =  <!-- A / B            / C / D / X -->
+| legal_status =
-| pregnancy_category=
-| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
-| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
-| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C -->
-| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
-| legal_status      =
 | routes_of_administration = [[Inhaler|Inhaled]], oral
+<!--Pharmacokinetic data-->
+| bioavailability =
+| protein_bound =
+| metabolism =
+| elimination_half-life =
+| excretion =
+<!--Identifiers-->
+| CAS_number_Ref = {{cascite|changed|??}}
+| CAS_number = 41570-61-0
+| ATC_prefix = R03
+| ATC_suffix = AC11
+| ATC_supplemental =
+| PubChem = 5606
+| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
+| DrugBank =
+| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
+| ChemSpiderID = 5404
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = 591I9SU0F7
+| KEGG_Ref = {{keggcite|correct|kegg}}
+| KEGG = D02151
+| ChEMBL_Ref = {{ebicite|correct|EBI}}
+| ChEMBL = 1159717
+<!--Chemical data-->
+| C=12 | H=18 | Cl=1 | N=1 | O=1
+| molecular_weight = 227.730 g/mol
+| smiles = Clc1ccccc1C(O)CNC(C)(C)C
+| InChI = 1/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3
+| InChIKey = YREYLAVBNPACJM-UHFFFAOYAO
+| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChI = 1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3
+| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChIKey = YREYLAVBNPACJM-UHFFFAOYSA-N
 }}
-{{CMG}}
 __NOTOC__
+{{SI}}
+{{CMG}}
 ==Overview==
+'''Tulobuterol''' ([[International Nonproprietary Name|INN]]) is a long-acting [[beta2-adrenergic receptor agonist]], marketed in Japan as a [[transdermal patch]] under the name '''Hokunalin tape''' (ホクナリンテープ).<ref>{{cite pmid|15212190}}</ref>
-'''Tulobuterol''' ([[International Nonproprietary Name|INN]]) is a [[beta2-adrenergic receptor agonist]].
+Currently, it is only legal in 6 countries: Japan, Germany, China, Bangladesh, Pakistan, and Venezuela.
+==References==
+{{reflist|2}}
+{{Adrenergic agonists}}
 {{Asthma and copd rx}}
 [[Category:Beta-adrenergic agonists]]
+[[Category:Phenethylamines]]
+[[Category:Organochlorides]]
-{{WikiDoc Help Menu}}
+[[Category:Drug]]
-{{WikiDoc Sources}}

v t e Adrenergic agonists
α	Template:Navbox subgroup
β	Template:Navbox subgroup
α and β	Epinephrine - Norepinephrine - Cirazoline - Etilefrine
Indirect/ mixed	Amphetamine - Tyramine - Ephedrine - Pseudoephedrine
see also acetylcholinesterase inhibitor

Clinical data


AHFS/Drugs.com	International Drug Names
Routes of administration	Inhaled, oral
ATC code	R03AC11 (WHO)
Identifiers
IUPAC name (RS)-2-(tert-butylamino)-1-(2-chlorophenyl)ethanol
CAS Number	41570-61-0^N
PubChem CID	5606
ChemSpider	5404^Y
UNII	591I9SU0F7
KEGG	D02151^Y
ChEMBL	ChEMBL1159717^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₂H₁₈ClNO
Molar mass	227.730 g/mol
3D model (JSmol)	Interactive image
SMILES Clc1ccccc1C(O)CNC(C)(C)C
InChI InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3^Y Key:YREYLAVBNPACJM-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

Tulobuterol: Difference between revisions

Revision as of 18:16, 8 April 2015

Overview

References

Navigation menu

Search